Entrada Therapeutics (NasdaqGM:TRDA) 2026 Conference Transcript

Entrada Therapeutics (NasdaqGM:TRDA) 2026 Conference February 11, 2026 04:00 PM ET Company ParticipantsDipal Doshi - CEOConference Call ParticipantsDebjit Chattopadhyay - Managing Director and Senior Biotech AnalystDebjit ChattopadhyayAfternoon, and thank you for joining us at Guggenheim's 2026 Emerging Outlook Biotech Summit. I'm Debjit, one of the therapeutic analysts, and next presenting company is Entrada Therapeutics. Joining us from Entrada is the CEO, Dipal Doshi. Thank you so much for making time fo ...